SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2026ACC: 0001961289-26-000004
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
+37.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
37.50K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+37.50K
Price / share
—
Trade value
—
% of position
11.9%
4/1/2026
316.12K→353.62K
Total
Net shares
+37.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/1/2026 | A · Award | +37.50K | — | — | 11.9% | 316.12K | 353.62K |
| Total | +37.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported